Table 2 Tumor-infiltrating CD66b/CD8-positive immune cells in the penile TMA (PE2081)
Pathological Grade | p value | |||
|---|---|---|---|---|
Grade 1 (n = 128) | Grade 2&3 (n = 47) | Unknown (n = 8) | ||
CD66b | 15 (23.8 ± 25.5) | 12 (31.8 ± 38.0) | 7.5 (14.4 ± 14.1) | 0.209 |
CD8 | 62 (58.3 ± 37.1) | 60.5 (56.8 ± 37.5) | 68.5 (59.9 ± 32.0) | 0.898 |
Anatomic Stage | ||||
Stage I (n = 147) | Stage II & III (n = 36) | |||
CD66b | 16 (28.7 ± 31.2) | 7 (15.9 ± 19.9) | 0.014 | |
CD8 | 65 (60.0 ± 36.5) | 35 (49.1 ± 38.2) | 0.183 | |